ANGELA PUCKETT: Open Payments
NPI 1407258817 · HAWESVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 44 payments from 15 companies in 2025. Trend: 2023 $909 · 2024 $637 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $221 |
| Corium, LLC | 9 | $129 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $34 |
| Tris Pharma Inc | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: VRAYLAR, Azstarys, Auvelity, INGREZZA, COBENFY, Jornay PM, ARISTADA, Dyanavel XR.
Industry payments across KY — which companies pay providers there.
